Clinical Trials Browser

Phase 2 × larotrectinib × Tumor-Agnostic × Clear all

NCT04879121 2025-10-30

Larotrectinib for the Treatment of NTRK Amplification Positive, Locally Advanced or Metastatic Solid Tumors

Phase 2 Recruiting

Neoplasm Metastasis